These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8289477)

  • 41. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
    Liebes L; Potmesil M; Kim T; Pease D; Buckley M; Fry D; Cho J; Adler H; Dar K; Zeleniuch-Jacquotte A; Hochster H
    Clin Cancer Res; 1998 Mar; 4(3):545-57. PubMed ID: 9533521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow culture.
    Sammons J; Ahmed N; Khokher MA; Hassan HT
    Stem Cells; 2000; 18(3):214-9. PubMed ID: 10840075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics.
    Wood PA; Hrushesky WJ; Klevecz R
    Exp Hematol; 1998 Jun; 26(6):523-33. PubMed ID: 9620286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Incidence of mutation and deletion in topoisomerase II mRNA of etoposide and m-AMSA resistant cell lines].
    Matsumoto Y; Morisaki K; Kunishio K; Nagao S; Takano H; Fojo T
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1145-9. PubMed ID: 9679576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of angiotensin II on hematopoietic progenitor cell proliferation.
    Rodgers KE; Xiong S; Steer R; diZerega GS
    Stem Cells; 2000; 18(4):287-94. PubMed ID: 10924095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperthermia, thermotolerance and topoisomerase II inhibitors.
    Kampinga HH
    Br J Cancer; 1995 Aug; 72(2):333-8. PubMed ID: 7640214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of cytotoxic drugs on the development of murine granulocyte-macrophage (GM) progenitor cells.
    Cylwik B; Szmitkowski M
    Mater Med Pol; 1992; 24(4):262-5. PubMed ID: 1308058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
    Backx B; Broeders L; Touw I; Löwenberg B
    Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: its therapeutic implication for MTAP (-) malignancies.
    Yu J; Batova A; Shao L; Carrera CJ; Yu AL
    Clin Cancer Res; 1997 Mar; 3(3):433-8. PubMed ID: 9815702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation between the DNA-binding affinity of topoisomerase inhibiting drugs and their capacity to induce hematopoetic cell differentiation.
    Gieseler F; Boege F; Clark M; Meyer P
    Toxicol Lett; 1993 Apr; 67(1-3):331-40. PubMed ID: 8383890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative toxicity of fostriecin, hepsulfam and pyrazine diazohydroxide to human and murine hematopoietic progenitor cells in vitro.
    Du DL; Volpe DA; Grieshaber CK; Murphy MJ
    Invest New Drugs; 1991 May; 9(2):149-57. PubMed ID: 1874599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of topoisomerase II in 32D.3(G) cells by hydroquinone is associated with cell death.
    Fung J; Hoffmann MJ; Kim DD; Snyder R
    J Appl Toxicol; 2004; 24(3):183-8. PubMed ID: 15211611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of type II topoisomerase by fostriecin.
    Boritzki TJ; Wolfard TS; Besserer JA; Jackson RC; Fry DW
    Biochem Pharmacol; 1988 Nov; 37(21):4063-8. PubMed ID: 2847752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA topoisomerase II inhibitors enhance random integration of transfected vectors into human chromosomes.
    Fujimaki K; Aratani Y; Fujisawa S; Motomura S; Okubo T; Koyama H
    Somat Cell Mol Genet; 1996 Jul; 22(4):279-90. PubMed ID: 9000172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line.
    Reuveni D; Halperin D; Shalit I; Priel E; Fabian I
    Int J Oncol; 2010 Aug; 37(2):463-71. PubMed ID: 20596674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of effects of fostriecin, novobiocin, and camptothecin, inhibitors of DNA topoisomerases, on DNA replication and repair in human cells.
    Gedik CM; Collins AR
    Nucleic Acids Res; 1990 Feb; 18(4):1007-13. PubMed ID: 2156221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitro.
    Backer LC; Allen JW; Harrington-Brock K; Campbell JA; DeMarini DM; Doerr CL; Howard DR; Kligerman AD; Moore MM
    Mutagenesis; 1990 Nov; 5(6):541-7. PubMed ID: 2175833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus.
    Stanulla M; Wang J; Chervinsky DS; Aplan PD
    Leukemia; 1997 Apr; 11(4):490-6. PubMed ID: 9096688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the DNA topoisomerase II inhibitor merbarone in male mouse meiotic divisions in vivo: cell cycle arrest and induction of aneuploidy.
    Kallio M; Lähdetie J
    Environ Mol Mutagen; 1997; 29(1):16-27. PubMed ID: 9020303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytotoxic activity of topoisomerase II inhibitors in primary cultures of tumor cells from patients with human hematologic and solid tumors.
    Larsson R; Nygren P
    Cancer; 1994 Nov; 74(10):2857-62. PubMed ID: 7954248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.